ASCO: Paclitaxel Bests New Drugs in Breast Cancer

Patients with metastatic breast cancer did just as well — and maybe better — with paclitaxel-based chemotherapy compared with two newer, more expensive agents, results of a randomized trial showed.
MedPage Today